Result Review BROKING | INVESTMENT BANKING | RESEARCH | DISTRIBUTION |DEPOSITORY

Trident Ltd .
17th January 2019 www.hemsecurities.com

COMPANY OVERVIEW

CMP Rs 71.25
Trident Group is a diversified group of businesses headquartered in Ludhiana of
Market Cap(cr.) Rs 3623.22 Punjab State in India. Trident Limited is the flagship company of Trident Group, a
BSE CODE 521064 USD 1 billion Indian business conglomerate. The group operates in five business
segments: Yarn, Bed Linen, Paper, Chemicals and Captive Power. The company is
NSE CODE TRIDENT
one of the largest yarn spinners in India, one of the world's largest terry towel
P/E manufacturers and the world's largest wheat straw based paper manufacturer.
Face Value Rs 10
Highlights
Book Value Rs 57.08
52 wk low/high 51/89  The Company declared interim dividend of 6% (i.e. Rs 0.6 per equity
share of Face Value of Rs. 10 each) on 15-10-2018 and another interim
P/BV 1.24
dividend of 12% (i.e. Rs 1.2 per equity share of Face Value of Rs. 10
Promoters 70.77% each), the record date being 25th January 2019.
Holding

QUARTERLY REVIEW
 Revenue from operations has increased by 12.39% on a YoY basis for the period ended on 31st December
2018. However, sequentially there is a fall of 7.19% in the revenue from operations.

 The revenue from operations for the quarter ended Dec-18 stood at Rs 1291.39 cr which was 18.35% higher
than the revenue from operations for the quarter ended Dec-17, which stood at Rs 1094.10 cr.

 The company reported profit after tax of Rs. 112.13 cr for Q2 FY-19 as compared to Rs.73.02 cr for the same
period in the previous year which is a 53.56 % increase.

 The EPS for quarter ended Dec-2018 was Rs. 5.50 per share as compared to Rs. 5.18 per share for the same
period in previous year.

FINANCIAL REVIEW (Rs. in Crore)

Particulars Dec-2018 Sept-2018 QoQ % Dec-2017 YoY %
Net Sales 1291.40 1391.50 -7.19 1094.11 18.03
Total Expenditure 1048.74 1130.42 -7.23 894.08 17.30
PBIDT (Excl OI) 242.66 261.08 -7.06 200.03 21.31
PAT 112.13 109.14 2.73 73.02 53.56
PBIDTM% (Excl OI) 18.79 18.76 0.16 18.28 2.79
PBIDTM% 21.96 19.47 12.79 21.17 3.73
PATM% 8.68 7.84 10.71 6.67 30.13
Adj. EPS(Rs) 2.20 2.14 2.80 1.43 53.85

For Private Circulation Only 1 Hem Research

www.hemsecurities.com

HEM SECURITIES LIMITED

MEMBER-BSE,CDSL, SEBI REGISTERED CATEGORY I MERCHANT BANKER

Sebi Registration No For Research Analyst: INH100002250

MUMBAI OFFICE: 904, A WING, 9 FLOOR, NAMAN MIDTOWN, SENAPATI BAPAT MARG,
PRABHADEVI STATION, LOWER PAREL,MUMBAI-400013 PHONE-+912249060000

JAIPUR OFFICE:: 203-204, JAIPUR TOWERS, M I ROAD,

JAIPUR-302001 PHONE- 00911414051000

GROUP COMPANIES

HEM FINLEASE PRIVATE LIMITED

MEMBER-NSE
HEM MULTI COMMODITIES PRIVATE LIMITED
MEMBER-NCDEX, MCX
HEM FINANCIAL SERVICES LIMITED
NBFC REGISTERED WITH RBI

For Private Circulation Only 2 Hem Research

www.hemsecurities.com

Disclaimer & Disclosure: This document is prepared for our clients only, on the basis of publicly available information and
other sources believed to be reliable. Whilst we are not soliciting any action based on this information, all care has been taken
to ensurethatthefactsareaccurate,fairandreasonable.Thisinformationisnotintendedasanofferorsolicitationforthepurchase
orsellofanyfinancialinstrumentandatanypointshouldnotbeconsideredasaninvestmentadvise.Readerisrequestedtorely on his own
decision and may take independent professional ad- vise before investing. Hem Securities Limited, Hem Finlease
PrivateLimited,HemMultiCommoditiesPvt.Limited,Directorsandanyofitsemployeesshallnotberesponsibleforthecontent. The
person accessing this information specifically agrees to exempt Hem Securities Limited, Hem Finlease Private Limited, Hem
Multi Commodities Pvt. Limited or any of its affiliates or employees from, any and all responsibility/liability arising from such
misuseandfurtheragreestoholdHemSecuritiesLimited,HemFinleasePrivateLimited,HemMultiCommoditiesPvt.Limited or any of
its affiliates or employees free and harmless from all losses, costs, damages, expenses that may be suffered by the person
accessing this information due to any errors and delays. The companies and its affiliates, officers, di- rectors, and employees,
including persons involved in the preparation or issuance of this material may from time to time, have long or short positions in,
and buy or sell the securities there of, company (ies) mentioned here in and the same have acted upon or used the information
prior to, or immediately followingthepublication.

Analyst Certification
The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or
issues, and no part of the compensation of the research analyst(s) was, is, or will be directly or indirectly related to the specific
recommendations and views expressed by research analyst(s) in this report.

For Private Circulation Only 3 Hem Research